ITGAV and pancreatic neoplasm: Consistent with these findings, we observed that both the mRNA and protein expression of ITGAV was significantly higher in pancreatic tumor samples compared to normal pancreatic tissue samples across seven independent datasets: GSE15471 (1.14‐fold) [26], GSE16515 (1.04‐fold) [28], GSE62452 (1.10‐fold) [30], GSE28735 (1.09‐fold) [31], GSE71729 (1.05‐fold) [27], GSE60980 (1.06‐fold) [29], and the CPTAC‐PDAC dataset (1.03‐fold) [32] (Fig. 1B,C).